X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA FULFORD INDIA SHASUN PHARMA/
FULFORD INDIA
 
P/E (TTM) x 123.9 398.8 31.1% View Chart
P/BV x 8.5 6.2 137.3% View Chart
Dividend Yield % 0.2 0.1 275.4%  

Financials

 SHASUN PHARMA   FULFORD INDIA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
FULFORD INDIA
Mar-14
SHASUN PHARMA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs94942 10.0%   
Low Rs46450 10.1%   
Sales per share (Unadj.) Rs214.2691.4 31.0%  
Earnings per share (Unadj.) Rs5.311.5 46.6%  
Cash flow per share (Unadj.) Rs15.815.4 103.0%  
Dividends per share (Unadj.) Rs1.002.00 50.0%  
Dividend yield (eoy) %1.40.3 497.9%  
Book value per share (Unadj.) Rs53.3380.0 14.0%  
Shares outstanding (eoy) m56.623.90 1,451.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.0 32.4%   
Avg P/E ratio x13.160.7 21.6%  
P/CF ratio (eoy) x4.445.3 9.8%  
Price / Book Value ratio x1.31.8 71.5%  
Dividend payout %18.717.4 107.4%   
Avg Mkt Cap Rs m3,9582,714 145.8%   
No. of employees `000NA0.4 0.0%   
Total wages/salary Rs m2,164505 428.4%   
Avg. sales/employee Rs ThNM6,073.0-  
Avg. wages/employee Rs ThNM1,137.4-  
Avg. net profit/employee Rs ThNM100.7-  
INCOME DATA
Net Sales Rs m12,1272,696 449.7%  
Other income Rs m229125 182.9%   
Total revenues Rs m12,3562,822 437.9%   
Gross profit Rs m1,009-46 -2,174.7%  
Depreciation Rs m59415 3,905.3%   
Interest Rs m41510 4,369.5%   
Profit before tax Rs m23054 423.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-7310 -757.5%   
Profit after tax Rs m30245 675.9%  
Gross profit margin %8.3-1.7 -483.5%  
Effective tax rate %-31.717.7 -179.1%   
Net profit margin %2.51.7 150.3%  
BALANCE SHEET DATA
Current assets Rs m6,8841,738 396.0%   
Current liabilities Rs m8,456545 1,552.4%   
Net working cap to sales %-13.044.3 -29.3%  
Current ratio x0.83.2 25.5%  
Inventory Days Days6248 127.2%  
Debtors Days Days1084 2,498.4%  
Net fixed assets Rs m4,97012 41,766.4%   
Share capital Rs m11339 290.5%   
"Free" reserves Rs m2,8751,443 199.2%   
Net worth Rs m3,0201,482 203.8%   
Long term debt Rs m1,8170-   
Total assets Rs m13,3472,077 642.7%  
Interest coverage x1.66.7 23.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.91.3 70.0%   
Return on assets %5.42.6 205.9%  
Return on equity %10.03.0 331.7%  
Return on capital %13.34.3 309.5%  
Exports to sales %46.40-   
Imports to sales %14.224.5 58.3%   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728659 262.1%   
Fx inflow Rs m5,84317 33,968.6%   
Fx outflow Rs m2,173673 322.8%   
Net fx Rs m3,669-656 -559.4%   
CASH FLOW
From Operations Rs m39890 441.8%  
From Investments Rs m-1,635105 -1,563.1%  
From Financial Activity Rs m1,309-14 -9,280.9%  
Net Cashflow Rs m71181 39.4%  

Share Holding

Indian Promoters % 39.2 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.6 3.8 94.7%  
FIIs % 17.6 0.1 17,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 21.2 186.8%  
Shareholders   20,750 4,783 433.8%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; IT Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the IT sector and power sector witnessing maximum selling pressure.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS